FINRA 8210 AML Investigation: 7 Critical Defense Facts

A FINRA 8210 AML investigation can put a stockbroker’s license, livelihood, and reputation on the line — often before the registered representative fully understands what regulators are actually looking for. If you have received a FINRA Rule 8210 request connected to anti-money laundering (AML) concerns, the answers you give about a customer’s source of funds, the red flags you did or did not escalate, and the way you respond to FINRA can decide whether the matter ends quietly or in a permanent bar from the industry.

This guide explains what a stockbroker’s AML duties really are, how far you can rely on a customer’s representations, who is responsible for the suspicious activity determination, and exactly what to do when a FINRA 8210 AML investigation lands in your inbox.

What Is a FINRA 8210 AML Investigation?

Quick answer: A FINRA 8210 AML investigation is an inquiry in which FINRA uses its authority under FINRA Rule 8210 to compel a registered representative or firm to produce documents, provide written information, and give on-the-record (OTR) testimony about possible anti-money laundering failures.

Rule 8210 is FINRA’s most powerful investigative tool. It allows staff to require any person subject to FINRA’s jurisdiction to testify and to hand over books, records, and account information relevant to an examination or investigation. When the underlying concern is AML — a suspicious deposit, an unexplained source of funds, a liquidation-and-wire pattern, or a missed SAR — the 8210 request becomes the vehicle FINRA uses to reconstruct what the broker knew and what the broker did about it.

Critically, responding is not optional. A registered representative who fails to respond completely and on time exposes themselves to a separate, and frequently career-ending, violation. That is why a FINRA 8210 AML investigation demands a careful, strategic response from the very first request.

What Are a Stockbroker’s AML Duties?

The anti-money laundering framework for broker-dealers is built on the Bank Secrecy Act (BSA), expanded by the USA PATRIOT Act and the Anti-Money Laundering Act of 2020, and implemented through FINRA Rule 3310. Rule 3310 requires every member firm to maintain a written AML program reasonably designed to detect and report suspicious activity.

Here is the distinction that matters most in an investigation: the AML program obligations belong to the firm, not to individual brokers / associated persons. The firm owns the program, designates an AML Compliance Officer, and files SARs. The registered representative sits on the front line of that program with a narrower — but very real — set of duties:

• Customer identification. Collect and confirm the identifying information required by the firm’s Customer Identification Program (CIP) under 31 CFR 1023.220.
• Source-of-funds and account-purpose inquiry. Ask the questions the firm’s procedures require about where a customer’s money comes from and how the account will be used.
• Ongoing awareness. Stay alert to activity that does not fit the customer’s profile as part of the firm’s ongoing customer due diligence.
• Promptly route anything that appears to be a red flag to the firm’s AML or compliance department.

In short, the broker’s job is to gather accurate information and escalate concerns. The firm’s job is to investigate those concerns and decide whether to file a SAR. Trouble begins when a broker treats the source-of-funds inquiry as a box-checking formality and passes along an answer they had reason to doubt.

Can a Broker Rely on a Customer’s Representations About Source of Funds?

Quick answer: Generally yes — but only when the reliance is reasonable. A broker may usually accept a customer’s plausible explanation of their source of funds, but blind reliance in the face of red flags is not a defense.

Two points must be separated. First, identity verification is mandatory. The CIP rule requires the firm to verify the customer’s identity to a reasonable belief. Second, source-of-funds verification is risk-based. There is no across-the-board federal mandate to independently verify every customer’s stated source of funds, as identity must be verified. For an ordinary account with no warning signs, taking a credible answer at face value is generally acceptable.

That permission disappears when red flags appear. The SAR standard asks whether the firm knows, suspects, or has reason to suspect that funds derive from illegal activity. “Reason to suspect” is an objective standard — meaning a broker cannot escape it by deliberately not asking, or by relaying an explanation they have reason to know is false or implausible. FINRA Regulatory Notice 19-18 catalogs the kinds of red flags that defeat reasonable reliance, including deposit-then-immediately-liquidate patterns, unexplained third-party wires, low-priced securities with no plausible acquisition story, and account activity that is wildly inconsistent with the customer’s stated means.

Does a Broker Have to Investigate and Verify the Customer’s Answer?

Quick answer: A broker has a duty to inquire and escalate — not a freestanding duty to investigate and verify. The investigative determination sits with the firm’s AML function.

The honest framing is this: the registered representative asks the questions the procedures require, exercises reasonable judgment about whether the answer is believable, and pushes anything questionable up to compliance. The representative does not have to run down every explanation, subpoena bank records, or personally decide whether to file a SAR. The firm’s AML department does the investigating and the deciding.

There are heightened-diligence exceptions. For private banking accounts, 31 CFR 1010.620 affirmatively requires the firm to ascertain the source of funds and the expected use of the account — in that context, source-of-funds development is mandatory rather than discretionary. But even in that setting, the program obligation runs to the firm, with the broker as the information-gathering front line.

Whose Job Is the SAR Determination — the Broker’s or the Firm’s?

The Suspicious Activity Report obligation belongs to the broker-dealer under 31 CFR 1023.320 and Exchange Act Rule 17a-8. An individual representative does not personally file SARs and does not make the firm-level “is this reportable” call. In that narrow sense, the broker reports up, and the firm decides.

But that is only half the picture — and the other half is where individual liability lives. Regulators reach individual representatives on a “causing” theory: if a rep fails to escalate red flags, and that failure causes the firm to miss a required SAR, the rep can be charged even though they never owned the program and never made the filing decision.

The point is not theoretical. In 2023, the SEC brought a settled enforcement action against an individual registered representative for failing to escalate red flags surrounding large, unusual transactions in a long-time customer’s account — conduct that caused his firm to miss a timely SAR filing. The representative, not just the firm, paid a penalty. The lesson for anyone in a FINRA 8210 AML investigation is direct: your escalation record — what you saw, and what you did with it — is usually the heart of the case.

Why AML Issues Trigger a FINRA 8210 AML Investigation

FINRA opens AML-related 8210 inquiries from many directions: a firm’s own SAR filing, a clearing-firm referral, a customer complaint, a regulatory tip, low-priced-securities surveillance, or a cycle examination that surfaces gaps in suspicious-activity monitoring. Once an issue is identified, FINRA frequently wants to know what the registered representative on the account knew and when.

Common fact patterns behind a FINRA 8210 AML investigation include:

• Deposits of low-priced or restricted securities followed by rapid liquidation and an outbound wire.
• Source-of-funds explanations that do not match the customer’s apparent finances or stated occupation.
• Third-party wires, journals between unrelated accounts, or funds moving to locations other than the customer’s home.
• A representative who was told about, or had reason to recognize, a red flag and did not escalate it.

Because reps are the front line, they are frequently the first individuals FINRA wants to put on the record — even when the firm’s program is the ultimate target.

What Happens If You Ignore a FINRA 8210 Request?

Quick answer: Ignoring or stonewalling an 8210 request can get you barred from the securities industry under FINRA Rule 9552 — often permanently — regardless of the merits of the underlying AML question.

FINRA Rule 9552 allows FINRA to suspend, and ultimately bar, any person who fails to provide information or testimony requested under Rule 8210. Many of the harshest outcomes in FINRA’s disciplinary history are not about the original misconduct at all — they are about the failure to respond, an incomplete production, or providing false or misleading information. Partial answers, missed deadlines, and “creative” responses can transform a survivable AML inquiry into an unsurvivable one.

That is precisely why a FINRA 8210 AML investigation should never be handled casually or alone.

How to Respond to a FINRA 8210 AML Investigation

If you have received an 8210 request tied to AML concerns, the early decisions matter most. General guidance — not a substitute for advice on your specific facts:

1. Engage experienced FINRA counsel immediately. Before you produce a single document or answer a single question, get counsel who handles 8210 matters and AML defense.
2. Preserve everything. Do not delete emails, texts, or notes. Spoliation turns a defensible case into an indefensible one.
3. Honor the deadline — or negotiate it. If you cannot meet the date, counsel can request an extension. Silence is not an option.
4. Be complete and accurate. Never guess, never minimize, and never provide information you have not verified. A false or incomplete answer is its own violation.
5. Prepare for the OTR. On-the-record testimony is where many AML cases are won or lost. Preparation with counsel is essential.
6. Build your escalation narrative. Your strongest defense is usually the record of what you saw and how you handled it. Counsel can help you marshal it.

How Bakhtiari & Harrison Defends Registered Representatives

Bakhtiari & Harrison represents registered representatives, financial professionals, and firms in handling a FINRA investigations, 8210 inquiries, on-the-record testimony, AML matters, and regulatory enforcement defense. We understand both sides of the AML framework — the firm’s program obligations and the individual’s narrower duty to gather information and escalate — and we use that understanding to protect our clients’ licenses and careers.

If you are facing a FINRA 8210 AML investigation, the window to shape the outcome is now open and will not remain open for long. Contact Bakhtiari & Harrison for a confidential consultation before you respond.

Call (310) 499-4732 or visit bhseclaw.com to speak with a securities attorney about your matter.

Frequently Asked Questions